GlassScriptPhysician profile
Joseph T Elliott
NPI 1669850269
$13,512.62
in general payments reported to CMS, 2019-2025
19 companies · $1,261 in 2025
The $1,261 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.36 · 2020: $41.94 · 2021: $43.73 · 2022: $2,836 · 2023: $5,439 · 2024: $3,870 · 2025: $1,261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,430 · Food and Beverage: $3,138 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,430.34 |
| Food and Beverage | $3,138.00 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,328.22 | 2022-2025 | Advisa Dr Mri Surescan, Concertotm, Turbohawk |
| Boston Scientific Corporation | $2,734.28 | 2022-2025 | Accolade Sr, Avvigo Guidance System, Emerge Push |
| Terumo Medical Corporation | $2,187.97 | 2022-2023 | Glidesheath Slender, Metacross Otw, R2p Misago |
| Edwards Lifesciences Corporation | $1,201.14 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abbott Laboratories | $452.61 | 2023-2025 | Xience Skypoint, Jeti, Jot Dx |
| Astrazeneca Pharmaceuticals LP | $118.99 | 2023 | Andexxa |
| Pfizer INC. | $110.26 | 2022-2024 | |
| Inari Medical, INC. | $70.55 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Lantheus Medical Imaging, INC. | $55.01 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $45.38 | 2024-2025 | Eliquis |
| Abiomed | $37.61 | 2024-2025 | Impella |
| Imperative Care, INC | $33.19 | 2024 | Zoom 88-T Large Distal Platform |
| Amgen INC. | $30.66 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $24.36 | 2025 | |
| Astellas Pharma US INC | $21.36 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $19.47 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.10 | 2025 | Lifevest |
| W. L. Gore & Associates, INC. | $13.80 | 2023 | Gore Cardioform Septal Occluder |
| Cardiva Medical, INC. | $12.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Elliott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.